Entegrion

Richard Martin, CFO of Entegrion, joined forty-four distinguished professionals as Triangle Business Leader and BDO Seidman LLP’s 2009 Top CFOs of the Triangle.

Entegrion, Inc., a privately owned life sciences product development company specializing in technologies for hemorrhage control, resuscitation, and tissue repair, was a winner in the 2009 New Product & Technology Awards.

Dr. Peter Johnson has joined life sciences company Entegrion as the new Executive Vice President and Chief Business Officer.

Dr. Thomas Fischer, the vice president and chief science officer at Entegrion, is scheduled to speak at the National Hemophilia Foundation’s 60th Annual Meeting, in Denver, C.O., the largest yearly gathering of the hemophilia community.

RTP-based Entegrion, which is developing blood coagulation and related technologies, is launching commercial sales of its Stasilon wound dressings that are designed to stop blood loss.

Entegrion, a Research Triangle Park-based company, has been awarded a contract with the Department of the Navy to develop an integrated dried plasma packaging and administration system for treating severely wounded patients under extreme conditions.

Life sciences company Entegrion will exhibit at the annual Advanced Technology Applications for Combat Casualty Care (ATACCC) Conference in Florida this week.

Life sciences company Entegrion continues to strengthen its leadership team with the addition of Michael Galiger, its new manufacturing and engineering manager. Galiger has more than 10 years of experience in medical and consumer products industries.

In a partnership with LC Industries of Durham, N.C., life sciences company Entegrion is now selling its FDA approved Stasilon™ - FR wound dressings in LC Industries-operated military base supply centers across the country.